Sofia Svensson Di Giorgio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sofia Svensson Di Giorgio has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Roberto Valente
Department of Diagnostics and Intervention, Surgery, Umeå University, 901 87 Umeå, Sweden
2 shared publications - Antonio Molinaro
Department of Molecular and Clinical Medicine, Wallenberg Laboratory University of Gothenburg Gothenburg Sweden
1 shared publication - Chiara Maria Scandavini
Department of Diagnostics and Intervention, Surgery, Umeå University, 901 87 Umeå, Sweden
1 shared publication - Urban Arnelo
Department of Diagnostics and Intervention, Surgery, Umeå University, 901 87 Umeå, Sweden
1 shared publication - Urban Arnelo
Department of Diagnostics and Intervention, Surgery, Umeå University, 90185 Umeå, Sweden
1 shared publication - Valeria Vespasiano
Gastroenterology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy
1 shared publication
Latest Publications
- Open Access
- 20 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 9109
The Role of ERCP in the Management of Primary Sclerosing Cholangitis: A Review
Primary sclerosing cholangitis (PSC) is a chronic inflammatory cholestatic liver disease of unknown aetiology, characterized by the progressive development of strictures involving the intrahepatic and extrahepatic biliary tree, ultimately leading to end-stage liver disease and an increased risk of cholangiocarcinoma. Approximately half of patients with PSC develop multiple biliary strictures over the course of the disease, which may result in infectious complications and obstructive jaundice. Importantly, these strictures may harbour dysplasia or malignancy; however, distinguishing benign inflammatory or fibrotic strictures from malignant lesions remains particularly challenging based on radiological findings alone. Endoscopy, particularly endoscopic retrograde cholangiopancreatography (ERCP), plays a pivotal role in both the diagnostic evaluation and therapeutic management of patients with PSC. In recent years, substantial advances have been made in endoscopic techniques aimed at improving diagnostic accuracy, with peroral cholangioscopy emerging as a particularly promising modality. In this review, we summarize the current role of endoscopic therapy and discuss recent and emerging advances in endoscopic diagnostic strategies for patients with PSC.
- 20 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 9109
Open AccessThe Role of ERCP in the Management of Primary Sclerosing Cholangitis: A Review
Primary sclerosing cholangitis (PSC) is a chronic inflammatory cholestatic liver disease of unknown aetiology, characterized by the progressive development of strictures involving the intrahepatic and extrahepatic biliary tree, ultimately leading to end-stage liver disease and an increased risk of cholangiocarcinoma. Approximately half of patients with PSC develop multiple biliary strictures over the course of the disease, which may result in infectious complications and obstructive jaundice. Importantly, these strictures may harbour dysplasia or malignancy; however, distinguishing benign inflammatory or fibrotic strictures from malignant lesions remains particularly challenging based on radiological findings alone. Endoscopy, particularly endoscopic retrograde cholangiopancreatography (ERCP), plays a pivotal role in both the diagnostic evaluation and therapeutic management of patients with PSC. In recent years, substantial advances have been made in endoscopic techniques aimed at improving diagnostic accuracy, with peroral cholangioscopy emerging as a particularly promising modality. In this review, we summarize the current role of endoscopic therapy and discuss recent and emerging advances in endoscopic diagnostic strategies for patients with PSC.
- Open Access
- 2 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1149
Primary Sclerosing Cholangitis: Diagnosis, Management, and Clinical Challenges
Primary sclerosing cholangitis is a rare, chronic, inflammatory disease of the biliary tree that leads to progressive ductal obliteration, hepatic dysfunction, and ultimately liver cirrhosis. Most patients eventually require liver transplantation or develop serious complications, the most severe being end-stage liver disease and cholangiocarcinoma. The global prevalence of PSC is rising and has been reported to reach up to 31.7 cases per 100,000 individuals, representing a significant challenge in both diagnosis and management. In this review, we aim to provide a clinically oriented overview of the diagnosis and management of PSC. Furthermore, we seek to highlight key challenges and areas of uncertainty that clinicians encounter in the diagnosis and treatment of patients with this complex disease.
- 2 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1149
Open AccessPrimary Sclerosing Cholangitis: Diagnosis, Management, and Clinical Challenges
Primary sclerosing cholangitis is a rare, chronic, inflammatory disease of the biliary tree that leads to progressive ductal obliteration, hepatic dysfunction, and ultimately liver cirrhosis. Most patients eventually require liver transplantation or develop serious complications, the most severe being end-stage liver disease and cholangiocarcinoma. The global prevalence of PSC is rising and has been reported to reach up to 31.7 cases per 100,000 individuals, representing a significant challenge in both diagnosis and management. In this review, we aim to provide a clinically oriented overview of the diagnosis and management of PSC. Furthermore, we seek to highlight key challenges and areas of uncertainty that clinicians encounter in the diagnosis and treatment of patients with this complex disease.